Can Understanding Long COVID-19 Teach Us About Chemo Brain?
Cognitive effects from COVID-19 and cancer treatment look very similar. Collaboration may lead to better treatment for both.
Progress Against Cancer
Cognitive effects from COVID-19 and cancer treatment look very similar. Collaboration may lead to better treatment for both.
Cancer cells exploit an aging “infrastructure” to threaten life in those 60 and older.
The FDA granted accelerated approval to selpercatinib to treat solid tumors harboring RET gene fusions. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to selpercatinib (Retevmo) for the treatment of adult...
The FDA granted full approval to selpercatinib for the treatment of patients with advanced lung cancer. The U.S. Food and Drug Administration (FDA) has approved selpercatinib (Retevmo) for the treatment of patients with locally...
Researchers highlight need for outreach and educational programs to address survivorship disparities.
Researchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
AACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
Air pollution research provides clues to how cancer starts, and KRAS-targeting drug appears to keep cancer at bay longer than standard of care, but questions remain.
Get your hearing checked periodically if you will be undergoing chemotherapy with neurotoxic effects.
Early-onset cancer is increasing globally, testing population-wide preventive DNA testing, and more from the week in cancer news.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More